Neutralization of SARS-CoV-2 Omicron BA.2 by Therapeutic Monoclonal Antibodies
H. Zhou, T. Tada, B. M. Dcosta, N. R. Landau
This study evaluates the neutralization of SARS-CoV-2 Omicron BA.2 by therapeutic monoclonal antibodies, finding reduced neutralization by several antibodies but retention of activity by the AZD8895+AZD1061 cocktail.